Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 USD | +0.77% | -0.46% | +52.42% |
Sales 2024 * | 24.2M 2.02B | Sales 2025 * | 14.52M 1.21B | Capitalization | 82.42M 6.88B |
---|---|---|---|---|---|
Net income 2024 * | -52M -4.34B | Net income 2025 * | -54M -4.51B | EV / Sales 2024 * | 3.41 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.68 x |
P/E ratio 2024 * |
-1.58
x | P/E ratio 2025 * |
-1.56
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.99% |
Latest transcript on Assembly Biosciences, Inc.
1 day | +0.77% | ||
1 week | -0.46% | ||
Current month | -0.99% | ||
1 month | +16.73% | ||
3 months | +12.53% | ||
6 months | +68.92% | ||
Current year | +52.42% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30/20/30 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 46 | 08/11 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 59 | 14/17/14 |
Gina Consylman
BRD | Director/Board Member | 52 | 20/20/20 |
William Ringo
CHM | Chairman | 78 | 01/14/01 |
Date | Price | Change | Volume |
---|---|---|---|
04/24/04 | 15 | +0.33% | 15 913 |
03/24/03 | 14.95 | -1.32% | 38,130 |
31/24/31 | 15.15 | +1.95% | 5,330 |
30/24/30 | 14.86 | -1.30% | 4,230 |
29/24/29 | 15.06 | -0.10% | 8,891 |
Delayed Quote Nasdaq, June 04, 2024 at 08:57 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.42% | 82.42M | |
+14.26% | 9.15B | |
-14.54% | 4.9B | |
+42.06% | 4.46B | |
+9.01% | 4.09B | |
+20.13% | 2.49B | |
-27.22% | 2.17B | |
+15.83% | 2.1B | |
-39.50% | 1.89B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ASMB Stock